The network presented in Figure 7 provides insights into the molecular mechanisms underlying glioma progression, particularly alterations in chromatin remodeling (ATRX), neurodevelopmental transcriptional regulation (OLIG2), DNA repair (MGMT), and metabolic reprogramming (IDH2). Here, OLIG2 is linked to central nervous system cancer.